leisure time -WSS

leisure time

author：fashion 2025-10-02 12:31:56 - browse：29

Adam's take main illustration — Molly Ferguson/STAT

The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech. Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline.

The consequences of these strategic blunders — arguably, self-inflicted — could imperil Bluebird’s independence, perhaps even its survival.

Bluebird priced Lyfgenia at $3.1 million, while Vertex Pharmaceutical set the cost of Casgevy, its competing sickle cell treatment also approved on Friday, at $2.2 million. Not only is Lyfgenia significantly more expensive, but its prescribing label carries a “black box” safety warning, which requires patients undergo regular blood monitoring for cancer risk. Casgevy has no similar monitoring requirement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Experts study whether long Covid risk adds up with each reinfection

WSS

Where are patients getting their prescriptions for GLP

WHO recommends second malaria vaccine

Kim Kardashian sparks debate on benefits of full

TB outbreak tied to bone grafts underscores testing shortcomings

Covid's long

6 solutions to address cancer drug shortages and others

hotspot

leisure time

focus

Affirmative action in medical school literally saved lives

After John Oliver segment, STAT readers share their opioid

Duchenne breakthrough therapy leaves behind pioneering families

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New oral drug delivery patch is modeled after octopus tentacles

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Some of the ways extreme heat will change life as we know it

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Who are the detained American citizens released from prison in Iran?

explore

Where are patients getting their prescriptions for GLP

Nobel honors Karikó and Weissman's enduring partnership

The history of OxyContin, told through Purdue Pharma documents

CDC overhauls leadership of center that led response to Covid

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Experts study whether long Covid risk adds up with each reinfection

knowledge

entertainment

hotspot

entertainment